Skip to content
CancerIndex

Publication

Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group.

Authors not recorded

Leukemia2023PMID 36309560PMC9883149stubpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CIVIC-20260908-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (2)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 2

Curated evidence

Evidence citing this paper (2)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
36309560
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–2 of 2 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
BCL9 Fusion1
(prognostic)B Lymphoblastic Leukemia/LymphomaCURATED_BROADERPrognosticBSupports Poor Outcome3submitted
EID12177

This study was an international, multi-center retrospective analysis of 107 patients with MEF2D rearrangements, with information collected from 14 different regional study groups. The aim was to asses… (full text at CIViC)

PMID 36309560 · Ohki et al., 2023 · Open in CIViC

civic
MEF2D Fusion1
(diagnostic)B-lymphoblastic Leukemia With MEF2D RearrangementUNRESOLVEDDiagnosticBSupports Positive3accepted
EID12176

This international, multi-center retrospective analysis examined characteristics of 107 cases of B- lymphoblastic leukemia (B-ALL) with MEF2D gene rearrangements (MEF2D-r), gathering information from… (full text at CIViC)

PMID 36309560 · Ohki et al., 2023 · Open in CIViC

civic